Search

everythinglearnresearchcommunity

for

Search:↓

Plasma is better than Ringer's lactate for hair graft survival and growth after transplantation.

Androgens can both increase body hair and cause scalp hair loss.

Skin can produce blood cells, often due to disease, which might lead to new treatments for skin and blood conditions.

Runx genes are important for stem cell regulation and their roles in aging and disease need more research.

The document concludes that more research is needed to understand airway repair and to improve tissue engineering for lung treatments.

Current therapies cannot fully regenerate adult skin without scars; more research is needed for scar-free healing.

Researchers developed a new method to test hair growth drugs and found that adult cells are best for hair growth, but the method needs improvement as it didn't create mature hair follicles.

Blocking Rab27a slows hair growth, while blocking Rab27b encourages it.

Combining specific inducers helps dermal papilla cells regain hair-forming ability.

Newborn screening and gene therapy are expected to improve outcomes for Omenn syndrome patients.

The document concludes that while some organisms can regenerate body parts, mammals generally cannot, and cancer progression is complex, involving mutations rather than a strict stem cell hierarchy.

Melanocytes produce melanin; their defects cause vitiligo and hair graying, with treatments available for vitiligo.

Aminoguanidine increases VEGF in stored hair micrografts, potentially improving their viability after transplant.

A new hydrogel made from human cells improves wound healing by working with immune cells to promote repair.

Lymphatic vessels are important for skin repair and could affect skin disease treatments.

Scientists are using clumps of special stem cells to improve organ repair.

Targeting the HEDGEHOG-GLI1 pathway could help treat keloids.

Cells lacking the Bax protein can outcompete others, leading to better tissue repair and hair growth.

There are many treatments for common hair loss, but more trials are needed to decide which are best.

ILC1-like cells may contribute to hair loss in alopecia areata.

ILC1-like cells can independently cause alopecia areata by affecting hair follicles.

ILC1-like cells may contribute to hair loss in alopecia areata and could be new treatment targets.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

New treatments for skin and hair repair show promise, but further improvements are needed.

Injecting platelet-rich plasma into the scalp stimulates hair growth, increases hair density, and treats hair loss effectively with minimal side effects.

Super-enhancers controlled by pioneer factors like SOX9 are crucial for stem cell adaptability and identity.

Hair follicle stem cells are controlled by their surrounding environment.

Multiple treatments work best for hair loss.

The conclusion is that future hair loss treatments should target the root causes of hair thinning, not just promote hair growth.

The secretome from mesenchymal stem cells shows promise for treating skin conditions and improving skin and hair health, but more research is needed.